HealthcareServices

Global Cell Viability Assays Market Performance Report: Global Trends 2026–2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell viability assays market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Cell Viability Assays Market in 2030?

The cell viability assays market has experienced rapid expansion in recent years. It is projected to increase from $1.73 billion in 2025 to $1.91 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. This market’s historical growth can be attributed to the broadening of in vitro research activities, rising pharmaceutical R&D expenditures, an increase in toxicology testing, the growing use of cell culture models, and the presence of standardized assay kits.

The cell viability assays market is expected to experience significant expansion in the upcoming years. Its size is projected to reach $2.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. This growth during the forecast period can be attributed to several factors, including the increasing demand for high-throughput drug discovery, the rising adoption of automated assay platforms, the expansion of personalized medicine research, a growing focus on assay miniaturization, and the increasing integration of imaging-based viability analysis. Prominent trends anticipated in this period encompass the increasing adoption of high-sensitivity viability assays, the rising use of microplate-based detection systems, the growing demand for multiparametric cell health analysis, the expansion of drug screening applications, and an enhanced focus on reproducible assay protocols.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

What Drivers Are Influencing Production Trends In The Cell Viability Assays Market?

The growing domain of cell-based therapeutics is anticipated to invigorate the expansion of the cell viability assay market in the coming years. Cell-based therapeutics refers to medical approaches that employ living cells to mend or substitute damaged tissue, address illnesses, or reinstate normal bodily functions. This progress in cell-based therapeutics is fueled by breakthroughs in biotechnology, escalating investments in regenerative medicine, the wider acceptance and application of cell therapies, and enhancements in cell engineering and manufacturing processes. Cell viability assays are instrumental in supporting cell-based therapeutics by confirming the vitality, operational capacity, and safety of the therapeutic cells, thus optimizing treatment outcomes and ensuring rigorous quality control. For instance, in 2023, according to information from the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the quantity of gene therapies in Phase III clinical trials rose by 10% in Q3 2023, marking the initial quarterly increase since Q3 2022. Therefore, the proliferation of cell-based therapeutics is a key driver for the growth of the cell viability assay market.

Which Segments Are Gaining Traction In The Cell Viability Assays Market?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Trends Are Projected To Support The Growth Of The Cell Viability Assays Market?

Leading entities within the cell viability assays market are actively engaged in creating advanced cell screening technologies aimed at enhancing precision and accelerating drug discovery processes. These cell screening innovations boost cell viability assays by facilitating high-volume, accurate, and swift examination of cellular well-being and reactions, consequently refining experimental setups and advancing the formulation of therapeutic approaches. An illustrative case occurred in May 2024, when Arralyze, a technology firm headquartered in Germany, unveiled CellShepherd, an advanced platform designed for single-cell analysis. This system employs exclusive nanowell glass arrays to condense cell-based assays, allowing for continuous, live monitoring. The self-contained unit provides accurate cell distribution, joint cultivation under sterile environments, and imaging capabilities using both brightfield and fluorescent channels. Its artificial intelligence-powered analysis ensures precise enumeration and monitoring of cells. This accessible platform meets the growing demand for exact single-cell investigations across biomedical and life science fields.

Who Are The Core Companies Influencing Trends In The Cell Viability Assays Market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Which Regions Are Projected To Dominate The Cell Viability Assays Market In The Coming Years?

North America was the largest region in the cell viability assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Viability Assays Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2026, By The Business Research Company

In Vitro Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795